Senior Manager of Financial Planning and Analysis, Cellares
$150-210k
+ Stock Options
Cell therapy manufacturing services provider
Be an early applicant
Cell therapy manufacturing services provider
201-500 employees
Be an early applicant
$150-210k
+ Stock Options
201-500 employees
Company mission
To accelrete access to life-saving cell therapies.
Role
Who you are
- Bachelor's and/or Master’s degree in Finance, Economics, Accounting, Engineering, or related; MBA preferred
- 10+ years of experience in highly analytical and results-oriented roles, including financial planning and analysis, management consulting, investment banking, or related
- Strong understanding of accounting, budgeting, forecasting, and business operations principles, processes, and systems
- Advanced financial modeling skills, including P&Ls, balance sheets, cash flow statements, and key performance indicators (KPIs)
- Experience managing and analyzing large datasets and ability to distill and present as clear and succinct executive-level insights
- Excellent problem-framing, problem-solving, and project management skills in a fast-paced, dynamic environment
Desirable
- Experience in high-growth, technology-driven companies, ideally within the life sciences or healthcare industry
- Experience with advanced Excel BI functionality and languages (Power Query (M), PowerPivot (DAX)) and visualization tools like PowerBI or Tableau
- Proficiency in SQL and Python and experience with commercial and emerging analytics tools, technologies, and languages
What the job involves
- This role will report to the VP of Finance, leading Corporate FP&A and partnering with our R&D, Commercialization, and G&A teams as we scale our rapidly growing business
- Own the company’s consolidated financial model and associated material used for executive, board, and investor meetings; lead discussions on the strategic implications of pricing, gross margin, cash flow management, investment, and other resource allocation decisions
- Lead the company’s Operating Plan process: partner with executives to develop, commit to, and attain financial plans supported by comprehensive models of the key metrics and physical inputs that drive financial results
- Monitor key metrics and provide real-time analysis and insights on progress and variances to plans and lead in-depth strategic financial analysis and recommendations during quarterly reviews
- Identity and assess focus areas across the business to improve gross margin, profitability, and cash flow, propose initiatives supported by robust analysis, and partner with business leaders to execute and attain targets
- Drive strategic decisions through business cases and models evaluating various capital allocation decisions including but not limited to R&D investments, BOM cost reductions, insourcing versus outsourcing, product pricing, and headcount planning
Our take
There is a significant need for efficient, scalable manufacturing of cell therapies in the biopharmaceutical industry. As demand for advanced treatments like CAR T-cell therapies rises, traditional manufacturing methods often struggle with scalability, high costs, and process failures, limiting patients' access to these lifesaving therapies.
In response, Cellares has developed the CEll Shuttle platform, an automated system designed for high-throughput cell therapy production. The Cell Shuttle can manufacture 16 batches simultaneously, cutting batch costs by up to 50%. By integrating advanced technologies for flow cytometry and cell sorting, Cellares enhances operational efficiency, providing comprehensive solutions that accelerate access to therapies.
Partnering with industry leaders like Kite, Bristol Myers Squibb, and Cabeletta Bio further strengthens its market position, showcasing the platform's potential impact. Along with over $355M in funding and a commercial-scale facility in New Jersey, Cellares is well-prepared to scale operations and meet global demand, positioning itself for future growth in the evolving cell therapy landscape.
Steph
Company Specialist at Welcome to the Jungle
Insights
Company
Funding (last 2 of 3 rounds)
Aug 2023
$255m
SERIES C
May 2021
$82m
SERIES B
Total funding: $355m
Company benefits
- Holidays & Flexible Vacation
- Parental Leave
- Comprehensive Healthcare
- 401k + Company Match
- Catered Onsite Meals
- Premium Technology
- EV Charging
- Professional Development
Company values
- Integrity: We honor commitments, communicate openly, and demonstrate the highest ethical standards
- Innovation: We create novel solutions to high-value problems
- Growth Mindset: We value curiosity, the willingness to learn, and the courage to grow beyond ourselves while emrbacing change
- Collaboration: We work as one team, encourage vulnerability & diverse perspectives, and treat each otherwith authenticity & respect
- Passion: We are dedicated to doing meaningful work, achieving exceptional results, and having fun along the journey
- Quality: We are committed to world class Quality in everything we do and build a culture that promotes transparency, ownership, and regulatory compliance based on our customers' needs
Company HQ
The East Side, South San Francisco, CA
Articles
Leadership
Fabian Gerlinghaus
(Co-Founder & CEO)Graduated from the University of Munich with a Master's Degree in Aerospace Engineering. Prior to co-founding Cellares in 2019, they were the CHief Innovation officer at Synthego.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job
View 3 more jobs at Cellares